Trial Profile
N-3 polyunsaturated fatty acids and adiponectin in patients with end-stage renal disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- Acronyms OPACH
- 05 Nov 2010 New trial record.